Jonathan Aschoff
Stock Analyst at Roth MKM
(0.02)
# 4,646
Out of 4,649 analysts
444
Total ratings
29.9%
Success rate
-20.7%
Average return
Main Sectors:
Stocks Rated by Jonathan Aschoff
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDCX Medicus Pharma | Maintained: Buy | $9 | $0.2801 | +3,113.14% | 4 | Aug 14, 2026 | |
| TENX Tenax Therapeutics | Maintained: Buy | $30 → $5 | $1.80 | +177.78% | 8 | Aug 10, 2026 | |
| REVB Revelation Biosciences | Maintained: Buy | $16 | $1.05 | +1,425.26% | 14 | Aug 7, 2026 | |
| ZVRA Zevra Therapeutics | Maintained: Buy | $21 | $11.32 | +85.51% | 18 | Aug 6, 2026 | |
| MBRX Moleculin Biotech | Maintained: Buy | $31 | $0.6122 | +4,963.70% | 17 | Aug 4, 2026 | |
| CELZ Creative Medical Technology Holdings | Maintained: Buy | $20 | $1.22 | +1,539.34% | 8 | Jul 6, 2026 | |
| NVCT Nuvectis Pharma | Rated: Buy | $20 → $33 | $18.96 | +74.05% | 3 | Jul 6, 2026 | |
| GOVX GeoVax Labs | Maintained: Buy | $10 | $0.718 | +1,292.76% | 15 | May 26, 2026 | |
| BFRI Biofrontera | Maintained: Buy | $9 | $1.30 | +592.31% | 12 | May 15, 2026 | |
| PTHS Pelthos Therapeutics | Maintained: Buy | $55 | $27.50 | +100.00% | 5 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $21 | $2.94 | +614.29% | 10 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 | $4.14 | +624.64% | 6 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $14 → $11 | $2.60 | +323.08% | 10 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 → $15 | $0.2259 | +6,540.11% | 10 | Apr 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 → $3 | $0.296 | +913.51% | 5 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 → $3 | $0.0001 | n/a | 8 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 → $2 | $0.0406 | n/a | 11 | Jun 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 → $11 | $1.31 | n/a | 5 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €12.00 | €2.89 | n/a | 5 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.915 | n/a | 5 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $0.59 | $0.08 | n/a | 1 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $36 | $4.17 | n/a | 9 | May 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 → $36 | $42.63 | n/a | 2 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $250 → $24 | $1.70 | n/a | 2 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $620 → $500 | $0.000001 | n/a | 3 | Dec 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 | $10.97 | n/a | 2 | Feb 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $1.35 | n/a | 1 | Jun 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 → $30 | $0.1831 | n/a | 3 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $0.145 | n/a | 5 | Oct 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $2.5 → $8 | $0.0001 | n/a | 5 | Sep 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 | $0.000001 | n/a | 4 | Aug 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $38 | $8.45 | n/a | 1 | Mar 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 | $0.0001 | n/a | 3 | Nov 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $8 | $1.09 | n/a | 17 | Nov 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $11 | $2.72 | n/a | 3 | Oct 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 → $26 | $2.17 | n/a | 2 | Jul 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $0.834 | n/a | 1 | Apr 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $0.001 | n/a | 8 | Sep 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $2.14 | n/a | 12 | Sep 13, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 | $0.3367 | n/a | 17 | Sep 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 | $213.67 | n/a | 5 | Aug 19, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $92 | $120.16 | n/a | 14 | Aug 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $0.3999 | n/a | 10 | Aug 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 → $16 | $41.95 | n/a | 11 | Aug 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $4 → $3 | $7.41 | n/a | 12 | Aug 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $48.74 | n/a | 21 | Aug 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $0.8728 | n/a | 12 | Aug 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 | $5.18 | n/a | 6 | Aug 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $23.00 | n/a | 16 | Aug 5, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $18 | $73.02 | n/a | 13 | Aug 4, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $0.000001 | n/a | 10 | Jul 6, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $489 | $803.48 | n/a | 18 | Mar 8, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $0.40 | n/a | 4 | Nov 12, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 | $0.8865 | n/a | 3 | Dec 8, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $67.34 | n/a | 3 | Oct 24, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $499.73 | n/a | 1 | Feb 26, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $1 | $1.65 | n/a | 1 | Jan 17, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $32.95 | n/a | 2 | Jun 29, 2012 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 → $11 | $98.66 | n/a | 2 | Apr 16, 2012 |
Medicus Pharma
Aug 14, 2026
Maintained: Buy
Price Target: $9
Current: $0.2801
Upside: +3,113.14%
Tenax Therapeutics
Aug 10, 2026
Maintained: Buy
Price Target: $30 → $5
Current: $1.80
Upside: +177.78%
Revelation Biosciences
Aug 7, 2026
Maintained: Buy
Price Target: $16
Current: $1.05
Upside: +1,425.26%
Zevra Therapeutics
Aug 6, 2026
Maintained: Buy
Price Target: $21
Current: $11.32
Upside: +85.51%
Moleculin Biotech
Aug 4, 2026
Maintained: Buy
Price Target: $31
Current: $0.6122
Upside: +4,963.70%
Creative Medical Technology Holdings
Jul 6, 2026
Maintained: Buy
Price Target: $20
Current: $1.22
Upside: +1,539.34%
Nuvectis Pharma
Jul 6, 2026
Rated: Buy
Price Target: $20 → $33
Current: $18.96
Upside: +74.05%
GeoVax Labs
May 26, 2026
Maintained: Buy
Price Target: $10
Current: $0.718
Upside: +1,292.76%
Biofrontera
May 15, 2026
Maintained: Buy
Price Target: $9
Current: $1.30
Upside: +592.31%
Pelthos Therapeutics
May 15, 2026
Maintained: Buy
Price Target: $55
Current: $27.50
Upside: +100.00%
May 14, 2026
Maintained: Buy
Price Target: $21
Current: $2.94
Upside: +614.29%
May 14, 2026
Maintained: Buy
Price Target: $30
Current: $4.14
Upside: +624.64%
May 5, 2026
Rated: Buy
Price Target: $14 → $11
Current: $2.60
Upside: +323.08%
Apr 2, 2026
Maintained: Buy
Price Target: $18 → $15
Current: $0.2259
Upside: +6,540.11%
Mar 2, 2026
Maintained: Buy
Price Target: $8 → $3
Current: $0.296
Upside: +913.51%
Jul 8, 2025
Maintained: Buy
Price Target: $4 → $3
Current: $0.0001
Upside: n/a
Jun 4, 2025
Maintained: Buy
Price Target: $9 → $2
Current: $0.0406
Upside: n/a
May 13, 2025
Maintained: Buy
Price Target: $13 → $11
Current: $1.31
Upside: n/a
May 12, 2025
Maintained: Buy
Price Target: €12.00
Current: €2.89
Upside: n/a
Oct 23, 2024
Downgraded: Hold
Price Target: n/a
Current: $0.915
Upside: n/a
Sep 3, 2024
Maintained: Buy
Price Target: $0.59
Current: $0.08
Upside: n/a
May 21, 2024
Rated: Buy
Price Target: $36
Current: $4.17
Upside: n/a
Mar 7, 2024
Maintained: Buy
Price Target: $25 → $36
Current: $42.63
Upside: n/a
Mar 5, 2024
Maintained: Buy
Price Target: $250 → $24
Current: $1.70
Upside: n/a
Dec 18, 2023
Maintained: Buy
Price Target: $620 → $500
Current: $0.000001
Upside: n/a
Feb 27, 2023
Maintained: Buy
Price Target: $14
Current: $10.97
Upside: n/a
Jun 15, 2022
Initiated Coverage: Buy
Price Target: $8
Current: $1.35
Upside: n/a
Apr 28, 2022
Maintained: Buy
Price Target: $4 → $30
Current: $0.1831
Upside: n/a
Oct 25, 2021
Reiterated: Buy
Price Target: $24
Current: $0.145
Upside: n/a
Sep 27, 2021
Upgraded: Buy
Price Target: $2.5 → $8
Current: $0.0001
Upside: n/a
Aug 30, 2021
Maintained: Buy
Price Target: $7
Current: $0.000001
Upside: n/a
Mar 11, 2021
Initiated Coverage: Buy
Price Target: $38
Current: $8.45
Upside: n/a
Nov 22, 2020
Maintained: Buy
Price Target: $18
Current: $0.0001
Upside: n/a
Nov 17, 2020
Downgraded: Sell
Price Target: $8
Current: $1.09
Upside: n/a
Oct 14, 2020
Reiterated: Buy
Price Target: $14 → $11
Current: $2.72
Upside: n/a
Jul 14, 2020
Maintained: Buy
Price Target: $13 → $26
Current: $2.17
Upside: n/a
Apr 20, 2020
Reiterated: Buy
Price Target: $9
Current: $0.834
Upside: n/a
Sep 15, 2016
Reiterated: Buy
Price Target: $14
Current: $0.001
Upside: n/a
Sep 13, 2016
Reiterated: Buy
Price Target: $4
Current: $2.14
Upside: n/a
Sep 9, 2016
Reiterated: Buy
Price Target: $55
Current: $0.3367
Upside: n/a
Aug 19, 2016
Reiterated: Buy
Price Target: $29
Current: $213.67
Upside: n/a
Aug 10, 2016
Reiterated: Buy
Price Target: $92
Current: $120.16
Upside: n/a
Aug 10, 2016
Reiterated: Buy
Price Target: $24
Current: $0.3999
Upside: n/a
Aug 9, 2016
Reiterated: Buy
Price Target: $24 → $16
Current: $41.95
Upside: n/a
Aug 9, 2016
Reiterated: Sell
Price Target: $4 → $3
Current: $7.41
Upside: n/a
Aug 9, 2016
Reiterated: Buy
Price Target: $28
Current: $48.74
Upside: n/a
Aug 9, 2016
Reiterated: Buy
Price Target: $26
Current: $0.8728
Upside: n/a
Aug 9, 2016
Reiterated: Buy
Price Target: $16
Current: $5.18
Upside: n/a
Aug 5, 2016
Reiterated: Hold
Price Target: n/a
Current: $23.00
Upside: n/a
Aug 4, 2016
Reiterated: Buy
Price Target: $16 → $18
Current: $73.02
Upside: n/a
Jul 6, 2016
Reiterated: Buy
Price Target: $8
Current: $0.000001
Upside: n/a
Mar 8, 2016
Initiated Coverage: Buy
Price Target: $489
Current: $803.48
Upside: n/a
Nov 12, 2015
Reiterated: Buy
Price Target: $5
Current: $0.40
Upside: n/a
Dec 8, 2014
Maintained: Buy
Price Target: $16
Current: $0.8865
Upside: n/a
Oct 24, 2014
Maintained: Hold
Price Target: n/a
Current: $67.34
Upside: n/a
Feb 26, 2013
Downgraded: Hold
Price Target: n/a
Current: $499.73
Upside: n/a
Jan 17, 2013
Downgraded: Sell
Price Target: $1
Current: $1.65
Upside: n/a
Jun 29, 2012
Reiterated: Buy
Price Target: n/a
Current: $32.95
Upside: n/a
Apr 16, 2012
Maintained: Buy
Price Target: $13 → $11
Current: $98.66
Upside: n/a